ETHYL 2-AMINO-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLATE HCL, 97.0%, 500mg

N,N-Dibenzylethenesulfonamide, 95%, 500mg

(2S,4S)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 25g

Chariot avec bagues de contraste de phase pour objectifs à contraste de phase S40 pour iScope

5-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid, 95.0%, 500mg

Indoline-6-carboxylic acid hydrochloride, 95.0%, 10g

tert-Butyl 4-hydroxy-3,3-dimethylpiperidine-1-carboxylate, 95.0%, 1g

Rostafuroxin, 98.07%, 10mg

3-(2-Methylbenzoyl)quinoline, 97.0%, 1g

4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid, 95.0%, 1g

(4-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 1g

3-Amino-5-(methylsulfonyl)benzoic acid, 95.0%, 250mg

Squalène, min 90%, pour synthèse, 1L, conditionnement verre